Type Whole antibody Target IGF-1R CAS Number 905703-97-1 | Source Human ATC code none ChemSpider none | |
Ganitumab a human monoclonal antibody against type 1 insulin-like growth factor receptor (IGF1R), designed for the treatment of cancers.
Ganitumab was developed by Amgen. A phase III clinical trial (for metastatic pancreatic cancer) was abandoned in August 2012.
References
Ganitumab Wikipedia(Text) CC BY-SA